Assembly Biosciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$4.25 |
Market Cap |
$375.07 M |
Shares Outstanding |
25.55 M |
Public Float |
22.35 M |
Address |
11711 North Meridian Street Carmel Indiana 46032 United States |
Employees | - |
Website | http://www.assemblybio.com |
Updated | 07/08/2019 |
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN. |